000 | 01451 a2200373 4500 | ||
---|---|---|---|
005 | 20250516045129.0 | ||
264 | 0 | _c20120413 | |
008 | 201204s 0 0 eng d | ||
022 | _a1538-8514 | ||
024 | 7 |
_a10.1158/1535-7163.MCT-10-0872 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWatson, Venita Gresham | |
245 | 0 | 0 |
_aGenomic profiling in CEPH cell lines distinguishes between the camptothecins and indenoisoquinolines. _h[electronic resource] |
260 |
_bMolecular cancer therapeutics _cOct 2011 |
||
300 |
_a1839-45 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
650 | 0 | 4 |
_aCamptothecin _xpharmacology |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 |
_aGenomics _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoquinolines _xpharmacology |
650 | 0 | 4 | _aOligonucleotide Array Sequence Analysis |
650 | 0 | 4 | _aQuantitative Trait Loci |
650 | 0 | 4 |
_aTopoisomerase I Inhibitors _xpharmacology |
700 | 1 | _aHardison, Nicholas E | |
700 | 1 | _aHarris, Tyndall | |
700 | 1 | _aMotsinger-Reif, Alison | |
700 | 1 | _aMcLeod, Howard L | |
773 | 0 |
_tMolecular cancer therapeutics _gvol. 10 _gno. 10 _gp. 1839-45 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-10-0872 _zAvailable from publisher's website |
999 |
_c21001047 _d21001047 |